Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.175 USD | -2.47% | +1.84% | -33.63% |
Financials (USD)
Sales 2024 * | 262M | Sales 2025 * | 357M | Capitalization | 253M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 1.99 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
-4.06
x | P/E ratio 2025 * |
-20.7
x | Employees | 306 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
Latest transcript on Coherus BioSciences, Inc.
1 day | -2.47% | ||
1 week | +1.84% | ||
Current month | +12.76% | ||
1 month | -10.53% | ||
3 months | -15.65% | ||
6 months | +38.12% | ||
Current year | -33.63% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 2.205 | -1.12% | 422 609 |
24-05-08 | 2.23 | -0.89% | 1,247,098 |
24-05-07 | 2.25 | +1.35% | 656,324 |
24-05-06 | 2.22 | -2.20% | 1,302,068 |
24-05-03 | 2.27 | +4.61% | 1,527,524 |
Delayed Quote Nasdaq, May 09, 2024 at 10:51 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.63% | 253M | |
+2.71% | 108B | |
+10.08% | 105B | |
+1.60% | 23.46B | |
-11.93% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.51% | 17.19B | |
+6.03% | 13.99B | |
+35.13% | 12.53B |
- Stock Market
- Equities
- CHRS Stock